Sentence examples for based on model compounds from inspiring English sources
spectroscopic measurements, based on model compounds prepared by reacting 6FDA with p-anisidine.
Potential interaction pathways based on model compounds are recommended including further decomposition of Maillard reaction products (MRPs) and surfactant synthesis, which indicate that glucose played an important role on pyrolysis of microalgal protein and lipid components.
Based on the model compounds study, a series of fluorinated phenylethynyl-terminated imide oligomers (F-PETIs) with different calculated molecular weights (Calc'd Mn) were synthesized by thermal polycondensation of 2,3,3′,4′-biphenyltetracarboxylic 2,3,3′,4′-biphenyltetracarboxylic′-oxydiacidine (3,4′-OdianhydrideF-PEPA or 6F-PEPA as the endcanding agent.
To evidence this carbonyl hydrosilylation onto an amide based polymer, an approach on model compounds (use of N-methylpropionamide) was carried out.
This paper describes the use of FS on a sodium ion conductor based on a model compound, the beta-alumina.
A series of derivatives were designed based on the model compound 1,4-divinyphenyl-bridged triphenylene, and the structures were studied using the AM1 method and density functional theory (DFT) at the B3LYP/3-21G B3LYP/3-21G
Based on the model-compound studies, the composition of polyphosphoric acid (PPA)/P2O5 mixture as an effective catalytic/dehydrative medium for the preparation of poly ether ketones) was optimized.
The present paper provides a brief description of the physiology of the relevant target sites, a conceptual model of the two modes of action underlying local effects in the URT and the eyes, and finally an empirical approach, based on well-studied model compounds, for the derivation of a default factor for interspecies differences.
The hPXR agonist predictions using the Bayesian model based on steroidal compounds (Ekins et al. 2009) classified all compounds other than mancozeb as agonists, based on the specified activity cutoff (Table 2).
We started the development of ligand-based pharmacophore models based on training set compounds with high activity (IC50 <100 nM) and several-fold selectivity for IKK-β over IKK-α.
